Myriad Genetics | MYGN - Current Assets


Myriad Genetics reported $289M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Agilent USD 4.69B 70M Jun/2026
Becton, Dickinson and Co. USD 8.32B 178M Sep/2026
Bio-Rad Laboratories USD 3.08B 58.1M Sep/2026
Bruker USD 2.16B 67.9M Sep/2026
Danaher USD 14.79B 1.41B Sep/2026
Illumina USD 3.04B 201M Sep/2026
J&J USD 56.35B 3.42B Sep/2026
Mettler Toledo International USD 1.38B 28.79M Sep/2026
Myriad Genetics USD 289M 23.8M Jun/2026
OraSure Technologies USD 222.94M 17.84M Jun/2026
Pacific Biosciences Of California USD 307.85M 30.78M Sep/2026
Quest Diagnostics USD 3.12B 273M Sep/2026
Quidel USD 1.45B 69.4M Sep/2026
Repligen USD 1.24B 41.43M Sep/2026
Revvity USD 1.86B 436.33M Sep/2026
Standard Biotools USD 497.3M 19.56M Sep/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Veracyte USD 467.88M 106.9M Sep/2026
Waters USD 3.9B 186M Jun/2026